Mesoblast Limited (ASX:MSB)
3.070
+0.120 (4.07%)
At close: Jan 9, 2026
Mesoblast Employees
Mesoblast had 81 employees as of June 30, 2025. The number of employees increased by 8 or 10.96% compared to the previous year.
Employees
81
Change (1Y)
8
Growth (1Y)
10.96%
Revenue / Employee
323.85K AUD
Profits / Employee
-1.92M AUD
Market Cap
3.94B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 81 | 8 | 10.96% |
| Jun 30, 2024 | 73 | -10 | -12.05% |
| Jun 30, 2023 | 83 | 6 | 7.79% |
| Jun 30, 2022 | 77 | -6 | -7.23% |
| Jun 30, 2021 | 83 | -19 | -18.63% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ramsay Health Care | 90,000 |
| Sonic Healthcare | 45,000 |
| CSL Limited | 29,904 |
| Ansell | 15,000 |
| Regis Healthcare | 12,000 |
| Cochlear | 5,500 |
| Telix Pharmaceuticals | 234 |
| Pro Medicus | 132 |
Mesoblast News
- 1 day ago - Mesoblast Stock Rises On Strong Year‑Over‑Year Growth In Ryoncil Sales - Benzinga
- 1 day ago - Mesoblast Surges As Flagship Product Ryoncil Delivers Strong Quarterly Sales Growth - Nasdaq
- 1 day ago - Ryoncil® Sales Increase 60% in December Quarter to US$35.1M - GlobeNewsWire
- 2 days ago - ASX 200 LIVE: ASX trims gains; Woodside, Santos rally on oil spike, Rio down 5pc - The Australian Financial Review
- 8 days ago - Mesoblast (MESO) Appoints New Non-Executive Chair - GuruFocus
- 8 days ago - Mesoblast Chair Jane Bell To Retire; Appoints Philip Facchina As Non-executive Chair - Nasdaq
- 8 days ago - Mesoblast Announces Changes to Board of Directors' Leadership Roles - GlobeNewsWire
- 11 days ago - Mesoblast Retires Senior Debt with Non-Dilutive, Lower Cost, Five-Year Credit Line - GlobeNewsWire